期刊文献+

Ⅰ型胶原吡啶交联终肽与强直性脊柱炎的临床相关性研究 被引量:5

Study on Clinical Relation of ICTP and Ankylosing Spondylitis
暂未订购
导出
摘要 目的探讨Ⅰ型胶原吡啶交联终肽(ICTP)与强直性脊柱炎(AS)的临床相关性。方法采用实验流行病学方法,对178例AS患者不同情况下血清ICTP阳性分布对比分析。结果OAS患者HLA—B27阳性率为72.47%(129/178),ICTP阳性率为74.16%(132/178),对HLA—B27与ICTP配对分析,x2=0.31,P〉0.05,差异无统计学意义。②AS患者骶髂关节炎X线不同级别ICTP阳性率分别为O级80%,Ⅰ级73.47%,Ⅱ级91.18%,Ⅲ级65%,Iv级0%,x2=31.86,P〈0.005,差异有统计学显著性意义,说明骶髂关节炎x线不同级别之间ICTP阳性率确有不同,其特点是:O级即有较高ICTP阳性率;除Ⅱ级外,ICTP阳性率显示从高到低的下降趋势;Ⅱ级ICTP阳性率为最高,N级最低。③AS血清ICTP的阳性率初诊患者(84.62%)显著高于复诊患者(63.22%),x2=10.62,P〈0.005,差异有统计学显著性意义。结论ICTP能够较客观地、准确地对AS进行临床评价,主要包括早期诊断、判断病情和评价临床疗效。故ICTP可作为AS临床的实验室重要参考指标。 Objective To probe the clinical relation between TCTP and AS. Methods It was prospectively explored that the serum ICTP in 178 cases of AS patients was tested. Results (1)HLA-B27 and ICTP positive rate 72.47%(129/178) and 74. 16% (132/178),HLA-B27 and ICTP analyzed was no different,P〉0. 05. (2)The ICTP positive rate in the different grades (0--Ⅳ ) were 80. 00% ,73.47% ,91.18%, 65.00% and 0% respectively. The statistical analysis was very significant among each grade(P〈0. 005),so the ICTP positive rate was truely different. (3)The ICTP positive rate of the first diagno- sis and treatment patients and the repeated diagnosis and treatment patients was 84.62% and 63. 22% respectively,the statistical analysis was remarkablely different(P〈0. 005) ,the former was significantly higher than the latter in the AS pa- tients. Conclusion The ICTP is able to evaluate objectively and accurately the clinical significance,it mainly includes early diagnosis,judging disease condition and treating effect ,so plays an important role in the AS clinical phase.
出处 《现代检验医学杂志》 CAS 2009年第4期94-96,共3页 Journal of Modern Laboratory Medicine
基金 基金项目:陕西省卫生厅科学研究基金(编号08807).
关键词 临床研究 相关性 强直性脊柱炎 Ⅰ型胶原吡啶交联终肽 clinical study inter-relation ~ankylosing spondylitis ICTP
  • 相关文献

参考文献9

  • 1姚凤祥.现代风湿病学[M].北京:人民军医出版社,1997:381,373.
  • 2Takeuchi S,Saitoh H.Bone-turnover metabolites as clinical markers of bone metastasis in patients prostatic carcinoma[J].Int J Urol,1997,4(4):368-373.
  • 3姜昊文,张元芳,丁强,王忠,瞿连喜,邓守真.PICP和ICTP诊断前列腺癌骨转移的价值[J].中华泌尿外科杂志,1999,20(5):288-290. 被引量:8
  • 4王宏,王玲,徐莘香.恶性肿瘤骨转移及骨损伤分子机制的研究进展[J].中国骨肿瘤骨病,2004,3(2):73-75. 被引量:5
  • 5乐爱平,赵旭兰,张经宇.Ⅰ型胶原吡啶交联终肽在类风湿关节炎患者血清中测定的临床意义[J].中华风湿病学杂志,2005,9(8):485-487. 被引量:7
  • 6Koizumi M,Ogata E.Bone metabolic markers as gauges of metastasis to bone:a review[J],Ann Nucl Med,2002,16(3):161-168.
  • 7Midieal DL.Anky Losing Spondylitis and HLA-B27[J].Ter Arkh,1992,64:106.
  • 8Risteoi J,Elomaa I,Niemi S,et al.Radioimmunoassay for the pyridinoline cross-linked carboxy-terminal telopetide of type Ⅰ collagen:a new serum marker of bone collagen degradation[J].Clin Chem,1993,39(4):635-640.
  • 9Garnero P,Ferreras M,Karsdal MA,et al.The type I collagen fragments ICTP and CTX reveal distinct enzymatic pathways of bone collagen degradation[J].J Bone Miner Res,2003,18(5):859-867.

二级参考文献29

  • 1[1]Hirohashi S, Kanai Y. Cell adhesion system and human cancer morphogenesis. Cancer Sci, 2003,94:575 - 581.
  • 2[2]Felding- Habermann B. Integrin adhesion receptors in tumor metastasis. Clin Exp Metastasis, 2003, 20:203 - 213.
  • 3[3]Hemler ME. VLA proteins in the integrin family, Structures, Functions, and their role on leukocytes. Annu Rev Immunol, 1990, 8:365- 400.
  • 4[4]Kostenuik PJ, Singh G, Suyama KL, et al. A quantitative model for spontaneous bone metastasis : Evidence for a mitogenic effect of bone on Walker 256 cancer cells. Clin Exp Metastasis, 1992, 10:403 -410.
  • 5[5]Juneja HS, Schmalsteig FC, Lee S, et al. Vascular cell adhesion molecule - 1 and VLA -4 are obligatory adhesion proteins in the heterotypic adherence between human leukemia/lymphoma cells and marrow stromal cells. Exp Hematol, 1993, 21:444 - 450.
  • 6[6]Jothy S. CD44 and its partners in metastasis. Clin Exp Metastasis,2003, 20:195 - 201.
  • 7[7]Hap M, Goltzman D, Tremblay G, et al. Rat prostate adenocarcinoma cells disseminate to bone and adhere preferentially to bone marrow-derived endothelial cells. Cancer Res , 1992, 52:4613 -4619,
  • 8[8]Hart CA, Scott LJ, Bagley S, et al. Role of proteolytic enzymes in human prostate bone metastasis formation: in vivo and in vitro studies. BrJ Cancer, 2002, 86:1136 -42.
  • 9[9]Moustakas A, Pardali K, Gaal A, et al. Mechanisms of TGF - beta signaling in regulation of cell growth and differentiation. Immunol Lett, 2002, 82:85-91.
  • 10[10]Cooper CR,Bhatia JK, Muenchen HJ, et al. The regulation of prostate cancer cell adhesion to human bone marrow endothelial cell monolayers by androgen dihydrotestoserone and cytokines. Clin Exp Metastasis, 2002, 19:25 - 33.

共引文献20

同被引文献44

  • 1Pavelka K. Early diagnosis of ankylosing spondylitis [J]. Vnitr Lek,2006,52(7/8): 726-729.
  • 2Deyo RA,Weinstein JN. Low back pain[J]. N Engl J Med,2001,344(5) :363-370.
  • 3Khan MA. Update on spondyloarthropathies[J]. Ann Intern Med,2002,136(12) :896-907.
  • 4Braun J, BoUow M, Remlinger G. et al. Prevalence oI spondylarthropathies in HLA-B27 positive and nega- tive blood donors[J]. Arthritis Rheum, 1998,41 (1): 58-67.
  • 5Rhdwaleit M,Sieper J. Early diagnosis of spondyloar- thritis with special attention to the axial forms[J]. Z Rheumatol, 2005,64 (8) : 524-530.
  • 6Lee YSL, Schlotzhauer T, Susan M, et al. Skeletal status of men with early and late ankylosing spondylitis. Am J Med, 1997,103:233-241.
  • 7Arnson Y, Amital H, Shoefeld Y. Vitamin D and autoimmu-nity. New eti- ological and therapentical considerations. Ann Rheum Dis, 2007,66: 1137-1142.
  • 8Boonstra A, Bah'at F J, Crain C, et al. 1.25-Dihydroxyvitamin D3 has a derect effect on nave CD4 + T cell to enhance the development of Th2 cells. J Immunol.2001.167 :4924-4980.
  • 9Eva Z, Peter S, Janos G, et al. Vitamin D deficiency in nudifferentiated connective tissue disease. Arthritis Res Ther,2008,10 : 123.
  • 10Hewison M, Freeman L, Hughes SV, et al. Differential regulation of vita- min D receptor and its ligand in human monocyte-derived dendritic cells. Immunology ,2003,170 : 5382-5390.

引证文献5

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部